Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Critical Reviews in Biotechnology is Scopus-indexed (Q1, CiteScore 20.6), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 0738-8551Verify ISSN ↗1549-7801Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biotechnology | 12 / 325 | 96th | Q1 |
| Applied Microbiology and Biotechnology | 6 / 134 | 95th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1983–present, best quartile Q1, CiteScore 20.6.
Critical Reviews in Biotechnology is Q1 in Biotechnology (rank 12 of 325) and Q1 in Applied Microbiology and Biotechnology (rank 6 of 134), by CiteScore 2025.
Critical Reviews in Biotechnology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 20.6, which places it in quartile Q1 at the 96th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.779, quartile Q1, with an H-index of 144.
Critical Reviews in Biotechnology is published by Taylor and Francis Ltd. Its print ISSN is 0738-8551 and its online ISSN is 1549-7801.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Critical Reviews in Biotechnology has an h-index of 168 and a 2-year mean of 10.31 citations per paper (OpenAlex). Its Scopus CiteScore is 20.6, quartile Q1. On 2-year citations it ranks #13 of 309 Scopus journals in Biotechnology.
Critical Reviews in Biotechnology published 48 papers in 2025; its busiest recent year was 2021 with 128. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2024–2026), authors are most often from China (29.9%), India (16%) and United States (6.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 3 retracted papers are recorded (2.1 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.